ADAMTS13 and atrial fibrillation: Patients with lower VWF and VWF/ADAMTS-13 levels had significantly higher risk for developing new-onset AF during follow-up, whereas patients with AF at inclusion had higher VWF and VWF/ADAMTS-13.